Table 5.

Percentage of p-SMAD3 activity relative to PBS controls at 1 and 48h post TGFβ neutralizing antibody treatment

	1D11ˆ	Anti-TGFβ1	Anti-TGFβ2	Anti-TGFβ3	Anti-TGFβ2+3
1 h	37 ± 6.85∗∗∗∗	66.9 ± 6.45∗	63.89 ± 7.55∗	77.48 ± 11.31	102.29 ± 10.72
48 h	32.58 ± 6.38∗∗∗∗	66.45 ± 13.57∗	42.93 ± 7.65∗∗∗∗	46.54 ± 3.13∗∗∗∗	39 ± 8.98∗∗∗∗

Average of three experiments ±SEM; 10 μg/mL neutralizing antibody used in respective treatments. Statistical comparisons employed one-way or two-way ANOVA followed by Dunnett's test. ∗p ≤ 0.05; ∗∗p ≤ 0.01; ∗∗∗p ≤ 0.005;∗∗∗∗p ≤ 0.0001